Aptly called "bench-to-bedside", translational research involves developing and testing new techniques and therapies for better disease management and patient care. This field plays a pivotal role in ensuring that discoveries realize their potential for real-world impact instead of staying confined to the lab.

Join us in exploring how two tools can accelerate translational cancer research. Human Somatic Mutation Database (HSMD) Professional is an expert-curated somatic knowledgebase that incorporates real-world cancer patient data, while QCI Interpret Translational (QCI-IT) is a variant annotation and interpretation tool that provides automated ACMG/AMP classification, phenotype-specific insights and more.

You’ll learn how:

• HSMD, which includes data from over 870K real-world oncology cases, provides easily accessible and reliable data for the identification of clinically significant and actionable mutations

• QCI-IT can process uploaded variant data to prioritize impacting symptoms, pathways and genes implicated in drug response or disease progression

• HSMD and QCI-IT can be used in tandem to efficiently transition from exploratory insights to actionable decisions